Function Health Collaborates With GRAIL to Offer Multi-Cancer Early Detection Test Nationwide [Yahoo! Finance]
GRAIL, Inc. (GRAL)
Company Research
Source: Yahoo! Finance
AUSTIN, Texas Dec. 4, 2024 /PRNewswire/ -- Function Health , a revolutionary health management platform empowering people to live 100 healthy years, announces a collaboration with GRAIL, Inc ., a healthcare company whose mission is to detect cancer early when it can be cured, to expand the reach of innovative cancer screening to transform cancer care. Function Health's 100,000+ members nationwide who are eligible will have access to GRAIL's Galleri test—a first-of-its-kind, clinically validated multi-cancer early detection (MCED) test that screens for multiple cancers with a simple blood draw—as an add-on to its comprehensive list of 100+ lab tests. In 2024, cancer will affect over two million people in the U.S., with more than 611,000 projected to lose their lives to the disease. This highlights an urgent need for proactive, accessible solutions. The Galleri test screens for a "fingerprint" of many of the deadliest cancers - before they become symptomatic. These include cancers we
Show less
Read more
Impact Snapshot
Event Time:
GRAL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRAL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRAL alerts
High impacting GRAIL, Inc. news events
Weekly update
A roundup of the hottest topics
GRAL
News
- GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare ConferencePR Newswire
- GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- Grail, Inc. (NASDAQ: GRAL) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $16.00 price target on the stock.MarketBeat
- GRAIL to Participate in Upcoming Investor ConferencesPR Newswire